You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Suppliers and packages for generic ingredient: LAROTRECTINIB SULFATE


✉ Email this page to a colleague

« Back to Dashboard


LAROTRECTINIB SULFATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bayer Hlthcare VITRAKVI larotrectinib sulfate CAPSULE;ORAL 210861 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-390-01 60 CAPSULE in 1 BOTTLE (50419-390-01) 2019-07-26
Bayer Hlthcare VITRAKVI larotrectinib sulfate CAPSULE;ORAL 210861 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-391-01 60 CAPSULE in 1 BOTTLE (50419-391-01) 2019-07-26
Bayer Hlthcare VITRAKVI larotrectinib sulfate CAPSULE;ORAL 210861 NDA Loxo Oncology, Inc. 71777-390-01 60 CAPSULE in 1 BOTTLE (71777-390-01) 2018-11-26
Bayer Hlthcare VITRAKVI larotrectinib sulfate CAPSULE;ORAL 210861 NDA Loxo Oncology, Inc. 71777-391-01 60 CAPSULE in 1 BOTTLE (71777-391-01) 2018-11-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing